V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158086 | 20060479 | 1.52 | 56.6 | Adjuvant (A) | 2019-12-07 | 2019-12-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101090256 |
| 20158088 | 20060480 | 1.74 | 82 | Adjuvant (A) | 2019-02-22 | 2019-02-22 | ECX | 02 | N | ECX | 101364120 |
| 20158090 | 20060481 | 1.8 | 77.3 | Palliative (P) | 2017-01-16 | 2017-02-11 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101341820 |
| 20158091 | 20060482 | 1.65 | 83 | Adjuvant (A) | 2019-12-30 | 2019-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100432410 |
| 20158094 | 20060483 | 1.73 | 82.6 | Adjuvant (A) | 2018-09-24 | 2018-09-27 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100114014 |
| 20158097 | 20060484 | 1.51 | 50 | Adjuvant (A) | 2016-05-06 | 2016-05-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100887508 |
| 20158100 | 20060485 | 1.73 | 61.2 | null | 2018-03-31 | 2018-04-05 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100410419 |
| 20158105 | 20060486 | 1.64 | 96.2 | Palliative (P) | 2016-02-22 | 2016-02-27 | ECX | N | N | ECX | 100505088 |
| 20158107 | 20060487 | 1.68 | 66.8 | Curative (C) | 2019-02-24 | 2019-02-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100790020 |
| 20158109 | 20060488 | 1.53 | 95.6 | Adjuvant (A) | 2016-11-18 | 2016-11-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101813577 |
| 20158110 | 20060489 | 1.77 | 65 | Palliative (P) | 2018-03-28 | 2018-03-31 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100598244 |
| 20158113 | 20060490 | 1.55 | 46 | Palliative (P) | 2016-03-16 | 2016-03-22 | ECX | N | null | ECX | 100670349 |
| 20158114 | 20060491 | 1.74 | 55.8 | Palliative (P) | 2020-01-16 | 2020-01-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100598668 |
| 20158117 | 20060492 | 1.46 | 62.35 | Neo-adjuvant (N) | 2018-12-02 | 2018-12-11 | ECX | N | N | ECX | 100522377 |
| 20158120 | 20060493 | 1.74 | 69.2 | Adjuvant (A) | 2019-12-28 | 2020-01-03 | CAPECITABINE + GEMCITABINE | 01 | N | CAPECITABINE + GEMCITABINE | 100990585 |
| 20158121 | 20060494 | 1.46 | 65.5 | Adjuvant (A) | 2018-10-16 | 2018-11-03 | ECX | N | N | ECX | 101809420 |
| 20158122 | 20060495 | 1.66 | 91.6 | null | 2016-03-28 | 2016-04-01 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101061396 |
| 20158124 | 20060496 | 1.7 | 85.4 | Palliative (P) | 2016-12-26 | 2016-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100095906 |
| 20158125 | 20060497 | 1.6 | 83.4 | null | 2017-06-01 | 2017-06-04 | ECX | N | N | ECX | 100612067 |
| 20158130 | 20060498 | 1.67 | 86.9 | Neo-adjuvant (N) | 2018-09-01 | 2018-09-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101644873 |
| 20158132 | 20060499 | 1.64 | 78.2 | Adjuvant (A) | 2016-10-01 | 2016-11-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101373606 |
| 20158134 | 20060500 | 1.57 | 78.6 | Neo-adjuvant (N) | 2017-09-13 | 2017-10-01 | ECX | null | N | ECX | 101627746 |
| 20158135 | 20060501 | 1.78 | 63.1 | Adjuvant (A) | 2018-07-12 | 2018-07-13 | ECX | N | N | ECX | 100807902 |
| 20158141 | 20060502 | 1.73 | 82 | null | null | 2020-02-10 | ECX | 2 | N | CAPECITABINE + GEMCITABINE | 101185359 |
| 20158142 | 20060503 | 1.56 | 91 | Neo-adjuvant (N) | 2017-04-11 | 2017-04-18 | ECX | N | N | ECX | 100672403 |
| 20158145 | 20060504 | 1.68 | 67.9 | Adjuvant (A) | 2017-12-06 | 2017-12-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100602694 |
| 20158146 | 20060505 | 1.78 | 73 | Neo-adjuvant (N) | 2018-06-27 | 2018-07-01 | ECX | null | N | ECX | 100478518 |
| 20158147 | 20060506 | 1.78 | 66 | Neo-adjuvant (N) | 2019-10-29 | 2019-11-19 | ECX | 02 | N | ECX | 100343238 |
| 20158148 | 20060507 | 1.66 | 115 | Curative (C) | 2017-01-12 | 2017-01-15 | ECX | 02 | N | ECX | 100553944 |
| 20158149 | 20060508 | 1.79 | 90 | Curative (C) | 2016-03-08 | 2016-04-04 | ECX | N | N | ECX | 101101331 |
| 20158150 | 20060509 | 0 | 101.2 | Adjuvant (A) | 2018-06-04 | 2018-06-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100719732 |
| 20158151 | 20060510 | 1.61 | 57 | Adjuvant (A) | 2017-06-26 | 2017-07-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100411521 |
| 20158154 | 20060511 | 1.47 | 80.7 | Neo-adjuvant (N) | 2017-03-27 | 2017-04-06 | ECX | N | N | ECX | 100668140 |
| 20158156 | 20060512 | null | null | Neo-adjuvant (N) | 2017-10-21 | 2017-10-28 | ECX | N | N | ECX | 100447357 |
| 20158158 | 20060513 | 1.73 | 83 | Palliative (P) | 2017-04-12 | 2017-04-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101357770 |
| 20158160 | 20060514 | 1.73 | 78 | Adjuvant (A) | 2020-01-10 | 2020-01-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101861693 |
| 20158161 | 20060515 | 1.48 | 58.8 | Adjuvant (A) | 2018-01-13 | 2018-01-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100646769 |
| 20158163 | 20060516 | 1.57 | 91 | Palliative (P) | 2018-04-01 | 2018-04-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101238031 |
| 20158164 | 20060517 | 1.5 | 52.8 | Neo-adjuvant (N) | 2017-11-21 | 2017-12-03 | ECX | 02 | N | ECX | 101719799 |
| 20158166 | 20060518 | 1.75 | 74.1 | Palliative (P) | 2017-02-13 | 2017-02-20 | ECX | N | N | ECX | 101390561 |
| 20158167 | 20060519 | 1.7 | 73 | Neo-adjuvant (N) | 2018-04-19 | 2018-05-08 | ECX | 02 | N | ECX | 101705194 |
| 20158168 | 20060520 | 1.76 | 69.6 | Adjuvant (A) | 2018-08-23 | 2018-09-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100883260 |
| 20158172 | 20060521 | 1.65 | 77 | Palliative (P) | 2016-12-22 | 2016-12-22 | ECX | 2 | N | ECX | 100961807 |
| 20158175 | 20060522 | 1.6 | 53.7 | Neo-adjuvant (N) | 2018-01-18 | 2018-01-23 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101395466 |
| 20158176 | 20060523 | 1.68 | 67.8 | Neo-adjuvant (N) | 2016-07-22 | 2016-08-06 | ECX | N | N | ECX | 100334468 |
| 20158178 | 20060524 | 1.54 | 71.7 | Palliative (P) | 2016-07-26 | 2016-08-09 | ECX | N | N | ECX | 101329204 |
| 20158179 | 20060525 | 1.7 | 94.6 | Palliative (P) | 2019-04-05 | 2019-04-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100935172 |
| 20158180 | 20060526 | null | 95.4 | Neo-adjuvant (N) | 2019-07-16 | 2019-07-23 | ECX | 2 | N | ECX | 101594375 |
| 20158182 | 20060527 | 1.78 | 56.9 | Neo-adjuvant (N) | 2019-09-18 | 2019-09-25 | ECX | 02 | N | ECX | 100707003 |
| 20158184 | 20060528 | 1.71 | 71.8 | Adjuvant (A) | 2018-07-04 | 2018-07-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100208854 |